Electrical Stimulation in Women With Pelvic Organ Prolapse
Evaluation of the Effects of Electrical Stimulation in Women With Pelvic Organ
1 other identifier
interventional
26
1 country
1
Brief Summary
The aim of this study is to search the effects of electrical stimulation on clinical symptoms such as pelvic floor muscle strength, stage of POP, symptoms of pelvic floor, quality of life and sexual function in women with pelvic organ prolapse (POP)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 24, 2021
CompletedFirst Posted
Study publicly available on registry
February 2, 2021
CompletedStudy Start
First participant enrolled
February 15, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 20, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2022
CompletedJanuary 24, 2024
January 1, 2021
7 months
January 24, 2021
January 23, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The prolapse stage will be measured with Simplified POP-Q
The measurements are taken when the Valsalva maneuver is performed while the patient is in the dorsal lithotomy position. According to the reference point of the hymen, It is measured at a total of 4 points: cervix, posterior fornix, anterior and posterior vaginal wall. The stage of prolapse is graded. Stage 0: There is no prolapse. Stage 1: The most distal part of the prolapse is more than 1 cm above the prolapse. Stage 2: The most distal part of the prolapse, between 1 cm above and 1 cm below the prolapse Stage 3: The most distal part of the prolapse protrudes more than 1 cm below the prolapse. Stage 4: Complete eversion of the lower genital tract
Change from baseline prolapse stage at 4 weeks and 8 weeks
Secondary Outcomes (5)
Pelvic floor muscle strength will be measured measured with PFX Perineometer device(Cardio Design Pty Ltd, Australia)
Change from baseline Pelvic floor muscle strength at 4 weeks and 8 weeks
The pelvic organ prolapse symptoms will be assessed by Pelvic Organ Prolapse Symptom Score(POP-SS).
Change from baseline the pelvic organ prolapse symptoms at 4 weeks and 8 weeks
The pelvic organ prolapse symptoms severity will be assessed by the Pelvic Floor Distress Inventory (PFDI-20) .
Change from baseline the pelvic organ prolapse symptoms severity at 4 weeks and 8 weeks
Patients' quality of life will be assessed using the Prolapse Quality of Life Scale (P-QOL).
Change from baseline quality of life at 4 weeks and 8 weeks
Patients' sexual function will be assessed by the Pelvic Organ Prolapse/Incontinence Sexual Function Questionnaire-12 (PISQ-12)
Change from baseline sexual function at 4 weeks and 8 weeks
Study Arms (2)
Electrical Stimulation group
EXPERIMENTALES and lifestyle advice have been applied ES application will be done 3 days a week for 8 weeks, 20 minutes. An informative brochure with lifestyle advice will be provided for both groups.
Sham Electric Stimulation group
SHAM COMPARATORSham ES and lifestyle advice have been applied Sham ES application will be done 3 days a week for 8 weeks, 20 minutes. An informative brochure with lifestyle advice will be provided for both groups.
Interventions
Current application will be made in the frequency range of 20-50 Hz. The Chattanooga (Intelect Neo) device with interfering current will be used for treatment, vacuum electrodes will be made in the form of 4 pole application. Two electrodes to the outside of the inguinal ligament, the other two electrodes will be placed on the upper inner part of the thigh.ES applications will be performed in the supine position with head and knee pillow supported.
The Chattanooga (Intelect Neo) device with interfering current will be used for treatment, vacuum electrodes will be made in the form of 4 pole application. Two electrodes to the outside of the inguinal ligament, the other two electrodes will be placed on the upper inner part of the thigh. The same device used in ES application to the sham group will be attached to the patients, however, active ES will not be issued from the device and only vacuum will turn on. ES applications will be performed in the supine position with head and knee pillow supported.
Eligibility Criteria
You may qualify if:
- Being in the age range of 18-65 ,
- Having stage1-2 symptomatic prolapse according to the POP-Q system,
- Being a volunteer and literate
You may not qualify if:
- Being pregnant,
- being stage 3-4 prolapse, Those whose evaluation parameters are missing and who do not regularly participate,
- Inadequate understanding and cooperation in treatment and evaluation parameters,
- Have malignant disease, urinary infection,
- accompanying neurological disease, diabetes mellitus and cardiopathy with complications,
- have electronic and metal implant, loss of sensation, sacral peripheral nerve lesion
- Patients with at least one of the kidney failure requiring hemodialysis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- KTO Karatay Universitylead
- Ankara Yildirim Beyazıt Universitycollaborator
- Necmettin Erbakan Universitycollaborator
Study Sites (1)
Selcuk University
Konya, 42090, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 24, 2021
First Posted
February 2, 2021
Study Start
February 15, 2021
Primary Completion
September 20, 2021
Study Completion
February 1, 2022
Last Updated
January 24, 2024
Record last verified: 2021-01
Data Sharing
- IPD Sharing
- Will not share